OMMOVY
DEAD
Serial Number
97388474
Owner
Fulcrum Therapeutics, Inc.Attorney
Gina A. BibbyFiling Date
Apr 29, 2022
OMMOVY Trademark
Serial Number: 97388474
OMMOVY is a trademark filed by
Fulcrum Therapeutics, Inc.
on April 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Gina A. Bibby WITHERS BERGMAN LLP
10250 Constellation Blvd., Suite 1400
Los Angeles, CA 90067
United States
Trademark Details
Filing Date
April 29, 2022
Registration Date
Not Registered
Goods & Services
Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy
Filing History
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 13, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 13, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 21, 2025 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 18, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2024 RCSC
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 18, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2023 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 10, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 28, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 28, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 28, 2022 CNSL
ASSIGNED TO EXAMINER
Nov 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2022 NWOS
NEW APPLICATION ENTERED
May 3, 2022 NWAP